Skip to content
envelope-open icon

sales@atlantiatrials.com

Food and Ingredient Development for Microbiome Modulation

Share this webinar on your network:

Humankind faces a crisis of non-communicable chronic diseases that encompass pathologies such as obesity (and its co-morbidities), inflammatory bowel diseases, allergies, and autoimmune diseases. Microbiome alterations (dysbioses) induced through lifestyle and diet have been implicated in this development. There is tremendous potential for the targeted modulation and restoration of gut microbiota composition and functionality to combat chronic diseases.

Duration: 60 mins
Food and Ingredient Development for Microbiome Modulation

Webinar Highlights

  • The latest innovations in the area of nutrition and functional ingredients that enable a targeted and health-oriented modulation and/or restoration of gut microbiome composition and function.
  • Advances in our ecological and mechanistic understanding of how dietary components interact with the gut microbiota in relation to health do now provide a solid foundation for the rational design of food products and medical foods for tangible health outcomes.
+
0
Watched by
0
Questions answered
Webinar

Host:

Andrea Doolan

Andrea Doolan

Andrea leads Atlantia sales and operations from their headquarters in Cork.


Chief Executive Officer
Atlantia Clinical Trials

Webinar

Speakers

Jens Walter

Jens Walter

Focuses on the evolutionary processes that have shaped the host-microbiome.


Professor
APC Microbiome Ireland

Sign Up to watch:

Food and Ingredient Development for Microbiome Modulation